Logo

Nuclear Medicine Technology

Blue Bar

Nuclear Medicine Imaging and Function Studies
of the Gastrointestinal System

Ectopic Gastric Mucosa


Review of Pathology Principle
Indications Procedure
Interpretation Artifacts
Other Modalities Case Studies
References Quiz

Review of Pathology

A Meckel's diverticulum is a pathologic sacculation of the ileum, usually about 2 to 6 cm in length, derived from the persistence of the omphalomesenteric (embryonic vitelline) duct at the point where it joined the ileum, about 50 to 100 cm from the ileocecal valve. It is a relatively common congenital anomaly, occurring in about 1% to 3% of the population. Most Meckel's diverticula are lined with ileal mucosa, but a little less than half are lined with an ectopic mucosa. The ectopic tissue most commonly present is gastric mucosa (~80%) but duodenal mucosa, jejunal mucosa, colonic mucosa, or pancreatic tissue may also be present.

Most Meckel's diverticula are asymptomatic but a small proportion (~4%) will produce complications sometime during the patient's lifetime. Generally just over half of these (~2% of total) present before the age of two. In children, the most common presentation is painless rectal bleeding which results from ulceration of the adjacent bowel by the pepsin and hydrochloric acid secreted by the Meckel's ectopic gastric mucosa. Bleeding with abdominal pain occurs less frequently. In adults obstruction, intussusception and infection are also common presentations.

A convenient way to remember the statistical information related to a Meckel's diverticulum is to remember the "Rules of 2":

  • occurs in ~2% of the population;
  • male to female ratio ~2:1;
  • is ~2 inches long;
  • is located on the ileum within ~2 feet of the ileocecal valve;
  • ~2% become symptomatic by age 2;
  • 2 major types of ectopic tissue - gastric and pancreatic;
  • 2 major complications - bleeding and obstruction.

Once identified as being present, the treatment for a Meckel's diverticulum is surgical removal.


Return to Top of this Page
Return to
Top of Page

Principle

The nuclear medicine procedure to detect the presence of a Meckel's diverticulum that contains functioning gastric mucosa is based upon the observation that Tc-99m pertechnetate is concentrated and secreted by the mucus secretory cells of gastric mucosa, both normal and ectopic. The uptake of Tc-99m pertechnetate in a Meckel's should have the same temporal characteristics as its concentration in the stomach.


Return to Top of this Page
Return to
Top of Page

Indications

To detect the presence of a Meckel's diverticulum that contains functioning gastric mucosa.


Return to Top of this Page
Return to
Top of Page

Procedure

Patient Preparation

The patient should be NPO for at least four hours prior to beginning the study. Fasting reduces the secretion by the mucosal cells of the stomach of Tc-99m pertechnetate into the lumen of the bowel where it may produce a false positive interpretation. Fasting also improves the visibility of a Meckel's diverticulum by decreasing the release of the Tc-99m pertechnetate concentrated by its ectopic gastric mucosa.

Pharmacologic agents may also be used during patient preparation to enhance the probability of observing the ectopic gastric mucosa in a Meckel's diverticulum.

Cimetidine:

Cimetidine is a competitive, reversible histamine H2 - receptor antagonist which results in a decreased production and release of hydrochloric acid by the stomach. Along with this, it inhibits Tc-99m pertechnetate secretion into the gastric lumen allowing for the continued accumulation of the pertechnetate in the gastric mucosa, both normal and ectopic. For pediatrics, the cimetidine dose is 20 mg / kg / day orally for two days prior to the study. For adults, 300 mg is administered orally four times per day for two days prior to the study.

Ranitidine:

Ranitidine is also a histamine H2 - receptor antagonist and exhibits actions similar to cimetidine. Ranitidine is administered by intravenous infusion over a period of 15 to 20 minutes at a dose of 1 mg/kg to a maximum of 50 mg. Imaging for ectopic gastric mucosa should not begin until one hour after the completion of ranitidine infusion.

Pentagastrin / Glucagon:

Pentagastrin is a synthetic analogue of gastrin, the hormone that stimulates gastric acid secretion. When administered, it increases the uptake of Tc-99m pertechnetate by both normal and ectopic gastric mucosa thus enhancing the visualization of a Meckel's diverticulum. However, pentagastrin also stimulates gastrointestinal motility and this latter action may both move Tc-99m activity away from the ectopic site making it difficult to locate and speed the movement of stomach activity into the bowel which may hinder interpretation. Pentagastrin is administered subcutaneously at a dose of 6 µg / kg fifteen minutes before the administration of Tc-99m pertechnetate.

Glucagon is the pancreatic hormone that stimulates conversion of glycogen to glucose in the liver. It also has a relaxing effect on the smooth muscle of the GI tract which inhibits the movement of Tc-99m pertechnetate secreted by both the stomach and a Meckel's diverticulum thus enhancing the ability to interpret a Meckel's study. Glucagon is also antagonistic to pentagastrin in that it decreases the uptake of Tc-99m pertechnetate by gastric mucosa. Glucagon is administered intravenously at a dose of 50 µg / kg ten minutes after the administration of Tc-99m pertechnetate.

Pentagastrin and glucagon are often used together.

Pharmacologic Interventions

See Patient Preparation above. Potassium perchlorate administered orally at a dose of 6 mg / kg of body weight after completion of the study will purge Tc-99m pertechnetate from the thyroid and reduce the radiation dose to the gland. The perchlorate must not be given prior to the procedure.

Radiopharmaceutical(s)

Technetium (Tc-99m) pertechnetate is used to image ectopic gastric mucosa. The radiopharmaceutical is administered intravenously at a dose of about 7.0 to 7.5 MBq / kg (190 to 200 µCi / kg) body weight for pediatrics and about 350 to 400 MBq (9.5 to 10.8 mCi) for adults.

Equipment

A LFOV gamma camera with a low energy, all purpose or high resolution parallel hole collimator interfaced to a nuclear medicine computer system is preferred. The camera's analyzer is set at 140 keV with a 15% or 20% window. The computer acquisition uses a 64 x 64 x byte matrix.

Image / Data Acquisition Parameters

The patient should be placed supine in the field of view with both the xiphoid and the symphysis pubis within the field of view.

The computer is set to acquire an anterior flow at a rate of 1 or 2 seconds / frame for 60 seconds followed by a stage two dynamic acquisition at 15 to 30 seconds / frame for 29 minutes.

For films, the gamma camera is set to acquire anterior flow images at a rate of 2 to 5 seconds / frame for 60 seconds. This is followed by 300k to 500k count static anterior images taken every 5 minutes for 30 minutes. The first image is taken for the determined count (e.g.: 500k) and the remainder are taken for the same time. At the end of the 30 minute period, right lateral and posterior images are acquired. If the presence of a Meckel's diverticulum is not immediately obvious on the 30 minute images, the patient is instructed to void and the anterior and right lateral (and possibly the posterior) images are repeated. Static images may also be obtained at 45 and 60 minutes if indicated.

An example of clinical protocols for the detection of Meckel's diverticulum have been posted by The University Hospital in London, ON and by The Society of Nuclear Medicine.


Return to Top of this Page
Return to
Top of Page

Interpretation of Results

In a normal study, the Tc-99m pertechnetate is observed during the flow phase in the large abdominal vessels, kidneys, spleen and liver. Vascular activity remains visible is these organs throughout the study. After about 5 minutes, activity is seen to increasingly accumulate in the stomach. Bladder activity increases as the pertechnetate is eliminated by the kidneys. Toward the end of the study, activity released from the stomach may be observed within the proximal small bowel.

The classic characteristic of a positive result for a Meckel's diverticulum is a small, persistent focal area of Tc-99m pertechnetate uptake in the right lower abdominal quadrant that is not consistent with the organs normally visualized. A lateral view will confirm its presence within the peritoneal cavity, generally located anteriorly. The level of activity in the Meckel's diverticulum is not normally visualized on the flow or blood pool images but increases in parallel with the stomach activity to become very prominent.

Although the right lower abdominal quadrant is the most common location for a Meckel's diverticulum, it can be located almost anywhere in the abdomen. Lateral, oblique and posterior views must be used to investigate any suspicious concentration of Tc-99m pertechnetate. because it is attached to the ileum, the location of a Meckel's diverticulum will often change with a change in patient position, unless it is also attached to the umbilicus by a fibrous cord. Post voiding images are necessary to ensure that a Meckel's diverticulum occurring in close proximity to the bladder is not missed.

The sensitivity (~90%) and specificity (~95%) of nuclear medicine imaging to locate a Meckel's diverticulum are very good but false positive and false negative interpretations may be made for a variety of reasons.

False positive interpretations of a Meckel's diverticulum can result from:

  • activity released from the stomach into the small bowel;
  • hyperemia and increased blood pooling in inflammatory lesions such as intussusception, appendicitis, Crohn's disease, ulcerative colitis or peptic ulcer;
  • visualization of the uterus in a menstruating female;
  • vascular disorders such as hemangiomas, arteriovenous malformations or abdominal vessel aneurysms;
  • hypervascularity associated with vascular neoplasms;
  • urinary tract abnormalities such as ectopic kidney, extrarenal pelvis, hydronephrosis or vesicoureteral reflux;
  • residual activity in the ureters or renal pelvis;
  • intestinal duplication (cyst) containing ectopic gastric mucosa.

Unlike a Meckel's diverticulum, vascular abnormalities tend to have higher activity on the flow phase which then decreases with time. Location, as determined from lateral, oblique and posterior views, and the activity - time sequence compared to that of the stomach also provide valuable information to reduce the incidence of false positives.

False negative interpretation can occur due to:

  • the diverticulum being too small and / or having insufficient ectopic gastric mucosa to be detectable;
  • washout of the Tc-99m pertechnetate from the ectopic gastric mucosa;
  • the diverticulum being obscured by normally visualized structures such as the bladder;
  • necrosis of the ectopic gastric mucosa;
  • poor methodology.

Despite the significant number of conditions that have the potential to contribute to a false interpretation, the actual number of false reports is less than 10%.


Return to Top of this Page
Return to
Top of Page

Common Technical Difficulties and Artifacts

Colonic purging or barium enemas can induce an inflammatory response in the colon that can potentially result in a false positive interpretation. Nuclear medicine localization of a Meckel's diverticulum is best performed before either of these procedures or several days after them. Also, for abdominal radiographic studies requiring barium contrast agents the possibility exists that residual contrast agent may attenuate the radiation released by the activity present in the diverticula and thus hinder its detection.

Potassium perchlorate will block the uptake of Tc-99m pertechnetate by gastric mucosa. It must not be administered before the study but may be given after completion of the study to reduce the radiation dose to the thyroid gland which also concentrates pertechnetate.


Return to Top of this Page
Return to
Top of Page

Other Modalities for Determining the Same or Similar Information

Radiographic procedures using barium contrast are generally not satisfactory for detecting a Meckel's diverticulum. Barium may fill a Meckel's that has a wide opening to the ileum but the sensitivity of the procedure as a diagnostic technique for detecting a Meckel's diverticulum is very low.

Plain film radiography may detect enteroliths that may occasionally be present within the diverticulum.


Return to Top of this Page
Return to
Top of Page

Case Studies

Case #1 has been posted by the Mallinckrodt Institute of Radiology at Washington University Medical Center. A 2½-year-old boy who presents with nausea, vomiting and melena.

Case #2 has been posted by the Mallinckrodt Institute of Radiology at Washington University Medical Center. A 2½-year-old male presents with a one day history of bloody stool. Sequential 3 minute anterior using Tc-99m pertechnetate are provided.

Case #3 is hosted by Brigham and Women's Hospital's Department of Radiology. A 20-year-old man described an acute episode of rectal bleeding. One minute images using Tc-99m pertechnetate are provided.

Case #4 is hosted by the Harvard University School of Medicine. A 27-year-old male presented with gastrointestinal bleeding.


Return to Top of this Page
Return to
Top of Page

Specific References

Pathology

Texts

Netter F, >>>

InterNet URL's

The Merck Manual of Diagnosis and Therapy. This manual is posted by Merck & Co. Choose the publications option. (http://www.merck.com)

Procedure

Texts

Bernier DR, Christian PE, Langan JK. Nuclear Medicine: Technology and Techniques. 3rd ed. St. Louis: Mosby - Year Book, 1994: 332 & 433.

Datz FL. Handbook of Nuclear Medicine. 2nd ed. St. Louis: Mosby - Year Book, 1993: 128 - 131.

Early PJ, Sodee DB. Principles and Practice of Nuclear Medicine. 2nd ed. St. Louis: Mosby - Year Book, 1995: 514 - 516.

Thrall JH, Ziessman HA. Nuclear Medicine: The Requisites. St. Louis: Mosby - Year Book, 1995: 248 - 252.

Wagner H, : 929 - 930, 932 & 1159.

Journals

Goel V. Meckel's Diverticulum in Seminars in Nuclear Medicine, Vol. XII #1, Jan. 1982: pages 97 & 98.

Park H-M, Duncan K. Nonradioactive Pharmaceuticals in Nuclear Medicine published in The Journal of Nuclear Medicine Technology, Vol. 22 #4, Dec. 1994: pages 240 - 249.

InterNet URL's

Review and Reference Notes on Nuclear Medicine. These notes are posted by Dr. S.C. Williams from the Madigan Army Medical Center, Tacoma WA.
<http://www.mamc.amedd.army.mil/WILLIAMS/NucMed/GI07.htm#RTFToC31>

Gastrointestinal Bleeding - Meckel's Diverticulum. A very brief overview posted by the Division of Nuclear Medicine within the Department of Radiology at The Children's Hospital associated with the Harvard University School of Medicine. The information on Meckel's diverticulum is located close to the bottom of the document. <http://nucmedweb.tch.harvard.edu/Patient/Gastrointestinal/>

Meckel's Scanning. An overview posted by the University of Iowa within their Virtual Hospital project. <http://indy.radiology.uiowa.edu/Providers/Textbooks/ElectricGiNucs/Text/Meckels.html>

Videos

Still looking.


Return to Top of this Page
Return to
Top of Page

Quiz


Return to Top of this Page
Return to
Top of Page
Return to Nuclear Medicine Gastrointestinal Home Page
Return to
Nuc Med G.I.
Home Page
Continue to Gastric Emptying Studies
Continue to
Next Study

©1998 - 2000 Lyle J. Goodin, BSc, MRT(N), ACNM
Originally developed August 15, 1998; Last revised April 16, 2000
Comments, suggestions or questions??? Please address them to Lyle Goodin at:

email lgoodin@idirect.com or
lgoodin@staff.michener.on.ca